Published

Psilocybin and MDMA for the treatment of trauma-related psychopathology.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: International review of psychiatry (Abingdon, England)
Date: 2021-05-01
Source: PubMed
DOI: 10.1080/09540261.2021.1919062
PubMed: 34121583

Authors

Bird CIV Modlin NL Rucker JJH

Watch author

Derived topics and classifications

psilocybin Depression PTSD Review Article Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 4 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex2026-06-28 Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy2026-03-01 Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications2025-03-07 Psilocybin and MDMA for the treatment of trauma-related psychopathology.2021-05-01

Related papers

Psychedelics’ Use as Medicine Hits Significant RoadblockPsychiatric News · 2024-06-12 Psychedelic Therapy Hits Another Milestone, But Caution UrgedPsychiatric News · 2021-07-22 Session on Psychedelics Sure to Be EnlighteningPsychiatric News · 2021-03-01 Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2The Journal of Clinical Psychiatry · 2021-02-23 Psychedelics for Psychiatric Disorders: More Research NeededPsychiatric News · 2020-04-13 Is Psychedelic Medicine on the Horizon?Psychiatric News · 2019-02-28 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCEPARIPEX-INDIAN JOURNAL OF RESEARCH · 2023-05-15